Give Your Brain a Boost: The Advent of Cognitive-enhancing Drugs

Apr 11, 2013

If you could take a pill which would help you pass an impending exam or meet a crucial project deadline, would you do so? Matt James at BioCentre discusses the development of cognitive- enhancing drugs, used primarily to improve the quality of life of patients, and how this has helped fuel an increasing lifestyle use of these ‘Smart Drugs’. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/04/3-Give-Your-Brain-a-Boost-The-Advent-of-Cognitive-enhancing-Drugs.pdf” type=”pdf”]Give Your Brain a Boost The Advent of Cognitive-enhancing Drugs[/prettyfilelink] ...

Read More

The $1000 Genome Odyssey

Apr 11, 2013

Scientists have discovered that the relationship between the human genome and disease has proven to be far more complicated than originally anticipated back in 2000, when Bill Clinton announced that the first human genome was sequenced by the Human Genome Project, and that diseases would be, from then on, much easier to cure. But as with any other field, the more we learn about something, the more we learn how little we actually know. Ivan Karabaliev at Eagle Genomics shares with you what he has found so far about the Holy Grail of genomic sequencing. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/04/2-The-1000-Genome-Odyssey.pdf” type=”pdf”]The $1000 Genome ...

Read More

Historic and Big Picture Views on Drug Development

Mar 6, 2013

The infrastructure of drug development has changed dramatically. No longer are new developments dominated by big pharmaceutical companies, as universities and biotechnology firms are taking drugs forward. However, the management of early studies has become more challenging as many tasks must be outsourced to specialists and virtual teams must be established. Keith Williams at Boyd Consultants offers a wider perspective from his research on the history of the pharmaceutical industry and its evolution over the last 200 years or more. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/03/1-Historic-and-Big-Picture-Views-on-Drug-Development.pdf” type=”pdf”]Historic and Big Picture Views on Drug Development[/prettyfilelink] ...

Read More

Denmark – The Heart of Life Sciences for Clinical Trials

Mar 6, 2013

The purpose of clinical trials is to test potential new medicines to obtain safety and efficacy data, or more specifically, information about potential adverse drug reactions and adverse effects of other treatments to provide new and improved treatments. Rasmus Beedholm-Ebsen at Invest in Denmark explains the reasons why Denmark excels when it comes to testing new medicine in clinical trials. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/03/6-Denmark-The-Heart-of-Life-Sciences-for-Clinical-Trials.pdf” type=”pdf”]Denmark The Heart of Life Sciences for Clinical Trials[/prettyfilelink] ...

Read More

Genesis Conference Review – Strategy for UK Life Sciences

Mar 6, 2013

Tony Jones at One Nucleus reviews how Genesis commenced as a platform to showcase London’s life science cluster to the world. Collaboration with One Nucleus Partner, SCRIP Intelligence, saw Genesis 2012 take another evolutionary step forward. Bringing greater deal case-study analysis, debate and showcasing to the conference agenda, the online partnering and an international exhibition enabled all delegates to go home with a return on their investment. [prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/03/5-Genesis-Conference-Review-Strategy-for-UK-Life-Sciences.pdf” type=”pdf”]Genesis Conference Review Strategy for UK Life Sciences[/prettyfilelink] ...

Read More